RamziAbboudMD

Oncology • Saint Louis, MO

Physician

Join to view full profile

Dr. Abboud is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abboud's full profile

Already have an account?

Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110
Phone+1 314-454-8304

Fax+1 314-454-5902

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2017 - 2020
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2014 - 2017
University of Rochester School of Medicine and DentistryClass of 2014

Certifications & Licensure

IL State Medical License 2020 - 2026
MO State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Alpha Omega Alpha University of Rochester, 2014
Inductee Alpha Omega Alpha Honor Medical Society

Publications & Presentations

PubMed

1 citations
Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor speci...
Hunter Cassidy Cochran, Michael Joseph Slade, Chang Liu, Feng Gao, Sonia Godbole
Leukemia & Lymphoma. 2024-12-01
Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation.
Ramzi Abboud, Mark A Schroeder, Michael P Rettig, Reyka G Jayasinghe, Feng Gao
Blood. 2024-11-22
3 citations
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.
Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, Martin Maiers, Javier Bolaños-Meade
Journal of Clinical Oncology. 2024-10-01

Abstracts/Posters

Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide
Ramzi Abboud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Itacitinib Helps Prevent Graft Versus Host Disease in Stem Cell Transplant RecipientsDecember 10th, 2024
HMN 2024: New Drug Tested to Reduce Side Effect of ‘Half-Matched’ Stem Cell TransplantsDecember 6th, 2024
Clinical Trial Tests New Drug to Reduce Side Effect of 'Half-Matched' Stem Cell TransplantsDecember 5th, 2024